![](/img/cover-not-exists.png)
Imatinib mesylate therapy in chronic myeloid leukemia patients in stable complete cytogenic response after interferon-alpha results in a very high complete molecular response rate
Giuliana Alimena, Massimo Breccia, Luigia Luciano, Fabrizio Quarantelli, Daniela Diverio, Barbara Izzo, Biagio De Angelis, Marco Mancini, Roberto Latagliata, Ida Carmosino, Mauro Nanni, Marco Picardi,Volume:
32
Year:
2008
Language:
english
Pages:
7
DOI:
10.1016/j.leukres.2007.06.008
File:
PDF, 205 KB
english, 2008